KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 98 filers reported holding KRONOS BIO INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,475 | -25.2% | 92,673 | -1.0% | 0.00% | – |
| Q2 2023 | $161,026 | -68.5% | 93,620 | -73.3% | 0.00% | – |
| Q1 2023 | $511,972 | -9.0% | 350,666 | +0.9% | 0.00% | – |
| Q4 2022 | $562,757 | -52.5% | 347,381 | -1.8% | 0.00% | – |
| Q3 2022 | $1,185,000 | -8.6% | 353,860 | -0.6% | 0.00% | – |
| Q2 2022 | $1,296,000 | -50.1% | 355,840 | -0.9% | 0.00% | – |
| Q1 2022 | $2,597,000 | -49.5% | 359,180 | -5.1% | 0.00% | -100.0% |
| Q4 2021 | $5,144,000 | -30.4% | 378,538 | +7.4% | 0.00% | 0.0% |
| Q3 2021 | $7,386,000 | -5.3% | 352,382 | +8.2% | 0.00% | 0.0% |
| Q2 2021 | $7,797,000 | +64.2% | 325,569 | +100.6% | 0.00% | 0.0% |
| Q1 2021 | $4,749,000 | -6.4% | 162,258 | -4.5% | 0.00% | 0.0% |
| Q4 2020 | $5,073,000 | – | 169,827 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $19,993,000 | 11.63% |
| Omega Fund Management, LLC | 3,818,283 | $27,606,000 | 5.65% |
| Nextech Invest Ltd. | 1,451,537 | $10,495,000 | 3.00% |
| Wildcat Capital Management, LLC | 1,438,232 | $10,398,000 | 2.66% |
| Artal Group S.A. | 1,542,954 | $11,156,000 | 0.47% |
| Perceptive Advisors | 2,421,142 | $17,504,000 | 0.35% |
| Alphabet Inc. | 1,438,232 | $10,398,000 | 0.34% |
| Casdin Capital, LLC | 583,436 | $4,218,000 | 0.19% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $3,814,000 | 0.19% |
| Samsara BioCapital, LLC | 78,131 | $565,000 | 0.14% |